SCARF2 and central nervous system cancer: Utilizing The Cancer Genome Atlas database, comprehensive analysis underscores the widespread expression of SCARF2 in GBM, with elevated SCARF2 levels correlating with an unfavourable prognosis amongst glioma patients.